通过免疫研究创新加速全民可及:免疫议程2030战略优先事项7的建议
本文介绍免疫议程2030(IA2030)战略优先事项7(SP7)关于研究与创新的建议,以国家需求为导向,通过能力建设和协作加强创新生态系统。SP7确定四个关键领域:需求导向创新、新产品服务与实践、实施证据、本地能力,旨在更有效利用研究与创新实现IA2030目标。
要点
- SP7以国家需求与优先事项为导向,通过能力建设和协作加强创新生态系统。
- SP7确定需求导向创新、新产品服务与实践、实施证据、本地能力四个关键领域。
- 战略干预借鉴全球疫苗行动计划与疫苗十年经验,强调本地创新和实施证据。
核心结论
- SP7提出的方法将维持对开发新疫苗和改进现有疫苗的关注,并增加对服务提供创新的关注。
- 监测与评估将促进国家层面的循证优先事项设定,并帮助全球研发议程扎根于社区需求。
- 这些方法旨在更有效利用研究与创新的力量,以应对未来挑战并实现IA2030的宏伟目标。
研究设计与样本
- 本文为免疫议程2030(IA2030)战略优先事项7(SP7)的建议文件,由SP7制定,聚焦研究与创新。
主要发现
- 研究与创新是迄今免疫许多成功的基础,并将在IA2030未来成功中发挥重要作用。
- SP7明确以国家需求与优先事项为依据,旨在通过国家、区域和全球层面的能力建设和协作加强创新生态系统。
- SP7确定四个关键关注领域:(1)需求导向创新,(2)新产品、服务与实践,(3)实施证据,(4)本地能力。
- 这些关键关注领域的战略干预应用全球疫苗行动计划和疫苗十年的经验,强调本地创新。
- 战略干预促进国家利用研究改善项目绩效和影响,并鼓励为开发和实施创新进行能力建设。
关键数值与推荐
- SP7确定四个关键关注领域:需求导向创新、新产品服务与实践、实施证据、本地能力。
- 监测与评估将促进国家层面的循证优先事项设定。
- 监测与评估将帮助全球研发议程扎根于社区需求。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Research and innovation have been fundamental to many of the successes in immunization thus far, and will play important roles in the future success of Immunization Agenda 2030 (IA2030). Strategic Priority 7 (SP7) of IA2030, which addresses research and innovation, is explicitly informed by country needs and priorities, and aims to strengthen the innovation ecosystem through capacity building and collaboration at country, regional, and global levels. SP7 identifies four key focus areas: (1) "needs-based innovation", (2) "new and improved products, services, and practices", (3) "evidence for implementation", and (4) "local capacity". Strategic interventions in these key focus areas apply the lessons of the Global Vaccine Action Plan and the "Decade of Vaccines" to emphasize local innovation, promote the use of research by countries to improve program performance and impact, and encourage capacity building for the development and implementation of innovations. The proposed approach will maintain a focus on the development of new vaccines and the improvement of existing vaccines, and increase attention to innovation in service delivery. Monitoring and evaluation will foster evidence-based priority setting at the country level and help to ground the global research and development (R&D) agenda in the needs of communities. Together, these approaches are intended to harness the power of research and innovation more effectively, to meet the challenges of the future and achieve the ambitious goals of IA2030.
引用
- Sarley D, Hwang A, Fenton Hall B, et al. Accelerating access for all through research and innovation in immunization: Recommendations from Strategic Priority 7 of the Immunization Agenda 2030. Vaccine. 2022. PMID: 36529593. doi:10.1016/j.vaccine.2022.11.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。